Pentapeptide-3, SNP-PP-3
GMP COA
135679-88-8
kg
99%
Chengdu
Chengdu Shengnuo, Shengnuo Biopharm
kg
2025-11-17
Semaglutide API,Tirzepatide API,Liraglutide API,Linaclotide API,Creatine Monohydrate,Copper Tripeptide-1
-
Product Description
-
Seller Information
-
DescriptionCertificatesBasic Info
-
Product Name:
Glycyl-L-prolyl-L-arginyl-L-prolyl-L-alaninamide
Other Name:Glycyl-L-prolyl-L-arginyl-L-prolyl-L-alaninamide;Vialox Peptide / Pentapeptide-3;GPRPA-NH2;Vialox, Pentapeptide-3;Pentapeptide-3/Vialox Peptide;(2S)-1-(2-aminoacetyl)-N-[(2S)-1-[(2S)-2-[[(2S)-1-amino-1-oxopropan-2-yl]carbamoyl]pyrrolidin-1-yl]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]pyrrolidine-2-carboxamide;L-Alaninamide, glycyl-L-prolyl-L-arginyl-L-prolyl-;Pentaeptide-3/Vialox Peptide
CAS No.:135679-88-8
Molecular Formula:C21H37N9O5
InChIKeys:BYWJFRMLHFQWSR-AJNGGQMLSA-N
Molecular Weight:495.58
Exact Mass:495.29176531
EC Number:000-000-0
Color/Form:White to off-white
Categories:
Characteristics-
Density:
1.54
PKA:13.59±0.20(Predicted)
Critical Temperature & Pressure:Keep in dark place,Inert atmosphere,Store in freezer, under -20°C
-
-
Seller Information
-
Business Type:
Manufactory
-
Main Products:
Semaglutide API,Tirzepatide API,Liraglutide API,Linaclotide API,Creatine Monohydrate,Copper Tripeptide-1
-
Location:
Chengdu Shengnuo Biopharm Co., Ltd.
-
Payment Terms:
TT against copy of documents,D/P,L/C,TT against B/L draft before shipment,100% TT in advance
-
Average lead Time:
365
-
Total Annual Revenue:
Above $100 million
-
Total Employees:
Above 1000
-
Year of Establishment:
2004
-
-
Country Product Purchase Quantity Date Posted Post an enquiry for this product